GCP
DXCM icon

Garda Capital Partners’s DexCom DXCM Stock Holding History

Garda Capital Partners’s Portfolio DXCM Stock Details DXCM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q3 		– Sell
-6,652
Closed -$581K – 160
2025
Q2 		$581K Sell
6,652
-30,342
-82% -$2.38M 0.01% 444
2025
Q1 		$2.53M Buy
36,994
+27,886
+306% +$2.28M 0.06% 307
2024
Q4 		$708K Sell
9,108
-277
-3% -$20.5K 0.05% 173
2024
Q3 		$629K Sell
9,385
-329
-3% -$27K 0.02% 448
2024
Q2 		$1.1M Buy
+9,714
New +$1.23M 0.04% 335

Other funds holding DXCM

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $110B AUM 4.8% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Jennison Associates
Jennison Associates New York $167B AUM 44.17% 1-Year Est. Return
UBS AM
UBS AM Chicago, Illinois $550B AUM 43.33% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $875B AUM 40.89% 1-Year Est. Return
Nuveen
Nuveen Charlotte, North Carolina $419B AUM 43.02% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Garda Capital Partners's DXCM Position: Q3 2025 in Review

Garda Capital Partners sold out of DexCom (DXCM) in Q3 2025, closing a stake of 6,652 shares — an estimated $581K sold.

Garda Capital Partners first reported a position in DXCM in Q2 2024 and held it in 5 quarters. The position peaked at $2.53M in Q1 2025. 911 funds tracked by Wall St. Rank hold DXCM as of Q3 2025.

  • Garda Capital Partners reported no remaining DexCom position as of Q3 2025 after selling out during the quarter.
  • Garda Capital Partners sold 6,652 DexCom shares in Q3 2025, an estimated $581K.
  • Garda Capital Partners first reported a position in DexCom in Q2 2024 and held it in 5 quarters.
  • Garda Capital Partners's DexCom position peaked at $2.53M in Q1 2025.
  • 911 funds tracked by Wall St. Rank held DexCom as of Q3 2025.

Based on Garda Capital Partners's 13F filing for Q3 2025, filed 10 Nov 2025.